Actor Sanchari Vijay Passes Away Due To Bike Accident; Family To Donate Organs

- Sanchari Vijay met with an accident while riding pillion on a two-wheeler
- Vijay suffered severe head injuries and was placed life support
- Sanchari Vijay's family has decided to donate his organs
Kannada actor Sanchari Vijay passed away after sustaining severe injuries in a bike accident on June 12, 2021. The 38-year-old was out with his friend Naveen to buy medicines on a two-wheeler on Saturday night. The bike skid and hit an electric pole, while the actor suffered severe brain injuries in addition to a subdural hematoma (brain bleeding). He underwent surgery for the same and was placed in the Neuro ICU with full life support. Vijay's friend also sustained injuries including a fractured leg but is said to be stable.
Also Read: Kannada Actor Sanchari Vijay Critical After Bike Accident In Bengaluru

Sanchari Vijay won his National Film Award for the film Naanu Avanalla Avalu
Kumar informed the media that the family has decided to donate the actor's organs. Sanchari Vijay's brother Siddhesh Kumar confirmed the news to the media. A TOI report quoted him saying, "The brain stem has stopped functioning, so we have decided to donate his organs. Vijay always believed in serving society, which we are fulfilling by donating his organs."
Earlier today, Apollo Hospitals, Bengaluru, issued a statement confirming that the actor was deeply unconscious and showing signs of brain failure. The family came forward and has consented for organ donation keeping in view the current irreversible brain damage.
"Neurologically he is deeply unconscious and is showing signs of brain failure. The family had come forward and consented for organ donation keeping in view the current irreversible brain damage. We will follow the guidelines as per organ donation protocol," read the statement.
The news has sent shockwaves across his fans and co-stars. Actor Sudeep was one of the first to announce Sanchari Vijay's death and tweeted a eulogy that read, " "Very, very disheartening to accept that Sanchari Vijay breathed his last." Sudeep, who had met the late actor before the lockdown, added, "Met him couple of times just before this lockdown... All excited about his next film that's due for release. Very sad. Deepest condolences to his family and friends. RIP."
undefinedVery very disheartening to accept that Sanchari Vijay breathed his last.
— Kichcha Sudeepa (@KicchaSudeep) June 14, 2021
Met him couple of times just bfr this lockdown,,,, all excited about his nxt film,, tats due for release.
Very sad.
Deepest Condolences to his family and friends.
RIP
Actor Danish Sait wrote, "How unfortunate is this. I just saw an article saying he was in the ICU, and now I read this. My condolences to Mr. Sanchari Vijay's family and friends. Rest in peace sir, your contribution to cinema will live forever."
undefinedHow unfortunate is this, I just saw an article saying he was in the ICU, and now I read this. My condolences to Mr. Sanchari Vijay's family and friends. Rest in peace sir, your contribution to cinema will live forever. https://t.co/fTzzAGmusm
— Danish Sait (@DanishSait) June 14, 2021
Sanchari Vijay began his career in 2011 in the Kannada film industry with the film Rangappa Hogbitna. He went on to in movies like Dasavala, Harivu, Oggarane, Killing Veerappan, Varthamana and Sipaayi. The film Naanu Avanalla Avalu got the actor his National Film Award.
Latest News
Jaiveer Mehra | Feb 5, 2026Honda Dio 125 X-Edition, Shine 125 Limited Edition LaunchedBoth special editions get a variant-specific colour scheme and graphics.1 min read
Seshan Vijayraghvan | Feb 5, 2026Tata Punch EV Facelift To Be Launched On February 20The electric version of Tata’s SUV-esque hatchback will be launched on February 20, 2026, and, like the petrol-powered version, it will receive a range of visual and feature upgrades.2 mins read
Bilal Firfiray | Feb 5, 2026Hyundai i20 Line-Up Now Starts At Rs 5.99 LakhThree variants of the Hyundai i20 have received a price rejig – Era, Magna and Magna Executive.1 min read
Jaiveer Mehra | Feb 5, 2026New Mercedes-Benz V-Class India Launch On March 3The V-class is set to return to the Indian market in Extra Long Wheelbase guise and is likely to be a CBU import.2 mins read
Seshan Vijayraghvan | Feb 4, 2026Skoda Kylaq Crosses 50,000 Units Sales MilestoneThe Kylaq has been the brand’s best-selling car, which has led to Skoda Auto India’s best-ever sales performance in 2025.1 min read
Seshan Vijayraghvan | Feb 4, 2026Volkswagen Tayron R-Line’s Pre-Bookings Open For Rs. 51,000Customers can pre-book the SUV for a token of Rs. 51,000; however, the price announcement will take place sometime later in February 2026.1 min read
Bilal Firfiray | Feb 4, 2026Volkswagen Tayron R-Line Review: Sensible Flagship For IndiaVolkswagen has introduced a made-in-India flagship SUV that offers space, comfort, performance, and German driving finesse in a practical three-row package. But is the Tayron R-Line good enough?6 mins read
Preetam Bora | Feb 2, 2026TVS NTorq 150 Road Test Review: Bigger, Better & More Efficient!We test the new TVS NTorq 150 out in the real world to get a sense of what it offers in terms of performance, dynamics and fuel economy.7 mins read
Bilal Firfiray | Jan 21, 2026Tata Punch Facelift Review: New Turbo Engine; Same Old SoulWith the update, the Tata Punch facelift retains its character of being a healthy runabout, which is perfect for Indian roads. But have these changes made it any better?7 mins read
Amaan Ahmed | Jan 17, 2026Bajaj Chetak C25 First Ride Review: Basic, Likeable E-Scooter For First-Time RidersThe Chetak C25, in quite a few ways, is poles apart from the larger and more powerful 30 and 35 Series models, but in its mannerisms, it is very much a Chetak.8 mins read
Bilal Firfiray | Jan 9, 2026Toyota Urban Cruiser Hyryder: 10,000 km Long-Term ReviewAfter spending over three months and 10,000 km with the Toyota Urban Cruiser Hyryder Hybrid, we were impressed by its real-world mileage, seamless hybrid, practical comfort, and Toyota reliability. Is it the best C-SUV then?5 mins read



























































































































